Drugs

New guidelines recommend topical NSAIDS as first-line treatment for musculoskeletal pain

Philadelphia — Two physician groups are recommending topical nonsteroidal anti-inflammatory drugs – with or without menthol gel – as a non-opioid “first-line therapy” for treating acute pain from non-low-back musculoskeletal injuries.

COVID-19 pandemic: FMCSA extends waiver for certain preemployment drug tests

Washington — The Federal Motor Carrier Safety Administration has granted to recently furloughed commercial motor vehicle drivers a 90-day waiver from certain preemployment drug testing requirements, in response to the COVID-19 pandemic.

Marijuana tops list of substances identified in CMV drivers’ failed drug tests: FMCSA

Washington — The first report to use data from the Federal Motor Carrier Safety Administration’s new Drug and Alcohol Clearinghouse shows that, from the database’s Sept. 28 launch through May, marijuana was the most common substance found in positive drug and alcohol tests among commercial motor vehicle drivers.

COVID-19 pandemic: NSC warns employers to prepare for a surge in addiction issues

Itasca, IL — In response to news that at least 30 states are reporting increases in fatal opioid overdoses amid the COVID-19 pandemic – coupled with an ongoing concern about mental illness and substance use disorders – the National Safety Council is calling on employers to address worker stress, as well as emotional and mental health, now and as traditional work functions resume.
- Digital Partners -

FMCSA seeks to close ‘loophole’ that lets CMV drivers who fail drug, alcohol tests get licenses

Washington — The Federal Motor Carrier Safety Administration is seeking input on a proposed rule that would ban states from issuing commercial driver’s licenses to drivers with existing drug or alcohol violations, in an effort to eliminate what it calls a “regulatory loophole.”

Hazardous drugs in health care: NIOSH requests input on draft documents

Washington — NIOSH is asking for stakeholder comment on three draft documents pertaining to hazardous drugs in health care settings.

‘No compelling evidence’ ibuprofen makes COVID-19 worse, CDC says

Washington — Taking ibuprofen or similar anti-inflammatory painkillers does not “worsen the course of disease” for people who contract COVID-19, a Centers for Disease Control and Prevention official recently said in response to conflicting information shared on social media.

Preventing opioid misuse: New guide for employers in rural areas

Washington — Aiming to assist rural communities in the fight against opioid misuse, the Office of National Drug Control Policy has partnered with the U.S. Department of Agriculture on a guide for employers.
- Digital Partners -

Respiratory hazards in the cannabis industry: Researchers say ag standards may apply

Berkeley, CA — Cannabis industry workers may be at increased risk of respiratory problems as a result of on-the-job exposure to various hazards, results of a recent study led by a University of Washington professor indicate.

NIOSH requests input on Workplace Supported Recovery Programs

Washington — NIOSH is seeking comment on an agency plan to conduct research and develop resources on Workplace Supported Recovery Programs, which assist workers and employers affected by the nation’s opioid epidemic and other substance misuse disorders.

Next Webinar

Current Issue

What's Trending

From our Partners

Earn recertification points

Board of Certified Safety Professionals

Take a quiz about this issue of the magazine and earn recertification points from the Board of Certified Safety Professionals.